Market Tracker

01/23 6:05pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

8.68
Data as of Jan 23
 -0.06 / -0.69%
Today’s Change
2.05
Today|||52-Week Range
11.68
-7.56%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close8.74
Today’s open8.71
Day’s range8.57 - 8.93
Volume406,599
Average volume (3 months)557,246
Market cap$332.4M
Dividend yield--
Data as of 4:00pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)-21.43%
Earnings growth (next 5 years)-5.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book2.92

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...+0.12+0.51%
DRNADicerna Pharmaceutic...-0.28-1.41%
SRNESorrento Therapeutic...-0.02-0.20%
CCXIChemoCentryx Inc+0.15+1.80%
Data as of 4:00pm ET, 01/23/2015

Financials

Next reporting dateMarch 16, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts